Business● Low1h ago · Nov 11, 2026, 2:08 AM
Capricor Therapeutics shares rise as FDA decision nears
GlobeAlert Desk · curated from Seeking Alpha Tech · North America
Capricor Therapeutics' shares are rising as a decision from the FDA approaches. This indicates investor anticipation regarding an upcoming regulatory announcement that could impact the company's future.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text. How we score stories.
GlobeAlert context
What the desk knows about this story
Threat level
0 Low
Scored from severity, scale, escalation potential and source agreement. Below the alert threshold.
Sources
1 publisher
Single-source so far. Treat details as unconfirmed until more publishers report.
Category
Business
Not flagged as developing.
North America theater · last 7 days
rising · 30 in the last 24h935
events logged
96
risk index / 100
Attacks & Assaults 458Robberies & Theft 205Shootings 161Rocket Launches 40Kidnappings 30
- Protest activity (112 reports)Protests · · now
- Conflict activity (162 reports)Conflict Events · · now
- Cyber activity (103 reports)Cyber Threats · · 12m ago
More in Business
Business14m agoEnergy Vault projects $600M-$700M 2027 revenue with $40M-$50M EBITDASeeking Alpha TechBusiness18m agoU.S. crude stockpiles rose 9M barrels last week, API saysSeeking Alpha TechBusiness21m agoZcash slips toward $1,000 amid derivative liquidations, outflowsSeeking Alpha TechBusiness29m agoSingapore wants a bigger slice of the global gold market. Is it too late to the party?CNBC